ALB and type 2 diabetes mellitus: It recommends SGLT-2i use in those patients with type 2 diabetes with an eGFR ≥ 30 mL/min/1.73 m2 and urinary albumin > 30 mg/g creatinine, particularly in those with urinary albumin > 300 mg/g creatinine.